The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease

Zhilin Ren; Liming Yan; Ning Zhang; Yu Guo; Cheng Yang; Zhiyong Lou; Zihe Rao

doi:10.1007/s13238-013-2841-3

Zhilin Ren, Liming Yan, Ning Zhang, Yu Guo, Cheng Yang, Zhiyong Lou, Zihe Rao. The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease[J]. Protein&Cell, 2013, 4(4): 248-250. doi: 10.1007/s13238-013-2841-3

Citation:

Zhilin Ren, Liming Yan, Ning Zhang, Yu Guo, Cheng Yang, Zhiyong Lou, Zihe Rao. The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease[J]. Protein&Cell, 2013, 4(4): 248-250. doi: 10.1007/s13238-013-2841-3

Citation:

Zhilin Ren, Liming Yan, Ning Zhang, Yu Guo, Cheng Yang, Zhiyong Lou, Zihe Rao. The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease[J]. Protein&Cell, 2013, 4(4): 248-250. doi: 10.1007/s13238-013-2841-3

The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease

Graphical Abstract

Abstract

FullText(HTML)

References (0)

The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease

Catalog

Export File

Citation

Format

Content